NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/01/2018
Back to search
Official data from USPTO
STASON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
09/01/2018
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
06/11/2007
Registration date
08/26/2008
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/01/2018
Last transaction
09/01/2018
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
05/25/1993
First use in commerce
05/25/1993
Drawing code
4
Owner type
03
Owner location
Irvine, CA
Examiner
WELLS, CHRISTOPHER
Law office
L60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Stason Pharmaceuticals, Inc.
Representatives
D. Whitlow Bivens Musick, Peeler & Garrett, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system for the treatment of inflammatory disorders; for use in dermatologyoncologyhematology and in tissue and organ in ophthalmology and for gastroenterological disorders
Publications
History of USPTO decisions and trademark events.
34 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/01/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/01/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/01/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
08/24/2018
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/26/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/11/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/11/2015
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/09/2015
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
01/15/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/09/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/19/2014
E815
TEAS SECTION 8 & 15 RECEIVED
12/19/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
08/26/2008
PUBO
PUBLISHED FOR OPPOSITION
06/10/2008
NPUB
NOTICE OF PUBLICATION
05/21/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/07/2008
CNEA
EXAMINERS AMENDMENT MAILED
05/07/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/07/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
05/07/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/07/2008
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/30/2008
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/28/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/14/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/14/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
03/26/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/26/2008
ALIE
ASSIGNED TO LIE
03/26/2008
PAPER RECEIVED
03/17/2008
FAXX
FAX RECEIVED
03/14/2008
CNRT
NON-FINAL ACTION MAILED
09/17/2007
CNRT
NON-FINAL ACTION WRITTEN
09/17/2007
DOCK
ASSIGNED TO EXAMINER
09/17/2007
NWAP
NEW APPLICATION ENTERED
06/15/2007
Continuous trademark protection
Get notified about every new filing that threatens STASON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.